A Phase 2, Exploratory Study to Investigate Safety and Efficacy of Doxycycline Monohydrate Hydrogel (NANODOX® HYDROGEL 1%) In Atopic Dermatitis
Latest Information Update: 11 Nov 2021
At a glance
- Drugs Doxycycline (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions; Proof of concept
- 26 Dec 2018 Status changed from recruiting to completed.
- 17 Jan 2018 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
- 17 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.